News By/Courtesy: Amaruvi Vijay Sudharshan | 27 Jul 2020 8:17am IST

HIGHLIGHTS

  • India's Bharat Biotech is developing a vaccine for the infamous coronavirus.
  • Two indigenously developed vaccines have gained the approval of Drug Controller General of India's for human clinical trials.
  • There will be safety trials on a small scale on humans, phase two would include about 100 humans and in phase 3, 1000s of people will be tested randomly across the population.

India's Bharat Biotech is developing a vaccine for the infamous coronavirus. The race to develop the vaccine is speeding up globally, with Oxford-AstraZeneca candidate the clear frontrunner. It is already in stage 3 human trials and it is expected that the vaccine would be released before September. 

Another candidate by US National Institutes of Health (NIH) and Moderna Inc is not far behind. There two are nearing the end of completion of the vaccine. Seven Indian companies are making the vaccine. They are Zydus Cadila, Serum Institute, Biological E, Bharat Biotech, Indian Immunologicals, Mynvax, and Panacea Biotec. 

Two indigenously developed vaccines have gained the approval of the Drug Controller General of India for human clinical trials. 

Vaccine development:

It is done in different phases. First, there is the pre-clinical stage, where the vaccines are tested against animals. This is to know whether antibodies are being produced in animals. Once the vaccine gets the approval then there are three phases.

There will be safety trials on a small scale on humans, phase two would include about 100 humans and in phase 3, 1000s of people will be tested randomly across the population. 

Indian vaccines are doing well currently. Globally, there are more than 200 vaccine candidates and about 15 are going to enter clinical trials.  Professor K. VijayRaghavan, the principal scientific adviser to the government, had said that 30 groups, including academic and industry players in India, are working on a vaccine against COVID-19. About 20 of them are keeping a good pace. Vaccine efforts in India were divided into four categories—mRNA (one component of the genetic material of the virus is injected), attenuated (a weak version of the virus), vector backbone, and adjuvant vaccines. 

COVAXIN: It is the vaccine being developed by Bharat Biotech in collaboration with ICMR. The Phase I and Phase II clinical trials, which were approved after pre-clinical studies demonstrated safety and immune response, will start across the country next month. The Central Drugs Laboratory (CDL) at Kasauli in Himachal Pradesh has been engaged in testing experimental batches of Bharat Biotech's COVID-19 vaccine Covaxin on a priority basis. India will win the war against COVID

 

This article does not intend to hurt the sentiments of any individual, community, sect, or religion etcetera. this article is based purely on the author's personal views and opinions in the exercise of the fundamental right guaranteed under Article 19(1)(a) and other related laws being a force in India, for the time being.

Section Editor: Pushpit Singh | 27 Jul 2020 11:08am IST


Tags : Coronavirus

Latest News







Copyright Kalyan Krishna MediaZ Private Limited. All rights reserved. Unless otherwise indicated, all materials on these pages are copyrighted by Kalyan Krishna MediaZ Private Limited. All rights reserved. No part of these pages, either text or image may be used for any purpose. By continuing past this page, you agree to our Terms of Service, Cookie Policy, Privacy Policy and Content Policies.